Are these cancer types those having a high p53 mutation frequency such as ovarian cancer, those having a high hazard ratio such as hematological malignancies, those having a higher p53 mutation frequency upon relapse, or the frequent spontaneous cancer types in p53-defective mice (lymphoma) and Li-Fraumeni Syndrome people (sarcoma)? This evidence concerns the gene TP53 and sarcoma.